康達新材(002669.SZ):大連齊化擬投建年產8萬噸電子級環氧樹脂擴建項目
格隆匯3月25日丨康達新材(002669.SZ)公佈,為深化落實康達新材料(集團)股份有限公司新材料產業鏈戰略佈局,進一步提升公司控股子公司大連齊化新材料有限公司(簡稱“大連齊化”)環氧樹脂產品產能,實現規模化效應,進行產品差異化競爭,大連齊化擬投資建設“8萬噸/年電子級環氧樹脂擴建項目”,最終投資金額以項目建設實際投入為準。總投資預計4億元,其中建設投資為29,787.8萬元,流動資金為10,212.2萬元,項目總投資額以實際投資建設情況為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.